Clinical trials in multiple sclerosis - The importance of the outcome measure

被引：0
|
作者：
Zajicek, J
Thompson, A
Hobart, J
机构：
[1] Peninsula Med Sch, Plymouth, Devon, England
[2] Derriford Hosp, Plymouth PL6 8DH, Devon, England
[3] UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2004年 / 75卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
013
引用
收藏
页码：1215 / 1215
页数：1
相关论文
共 50 条
  • [41] Use of the Multiple Sclerosis Functional Composite as an outcome measure in a phase 3 clinical trial
    Cohen, JA
    Cutter, GR
    Fischer, JS
    Goodman, AD
    Heidenreich, FR
    Jak, AJ
    Kniker, JE
    Kooijmans, MF
    Lull, JM
    Sandrock, AW
    Simon, JH
    Simonian, NA
    Whitaker, JN
    ARCHIVES OF NEUROLOGY, 2001, 58 (06) : 961 - 967
  • [42] Summary measure statistic for assessing the outcome of treatment trials in relapsing-remitting multiple sclerosis - Reply
    Liu, C
    Blumhardt, LD
    Po, ALW
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (04): : 553 - 554
  • [43] Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosis
    Cree, Bruce A. C.
    Cohen, Jeffrey A.
    Reder, Anthony T.
    Tomic, Davorka
    Silva, Diego
    Piani Meier, Daniela
    Laflamme, Annik K.
    Ritter, Shannon
    Leppert, David
    Kappos, Ludwig
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (14) : 2219 - 2231
  • [44] Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects
    Cohen, Jeffrey A.
    Reingold, Stephen C.
    Polman, Chris H.
    Wolinsky, Jerry S.
    LANCET NEUROLOGY, 2012, 11 (05): : 467 - 476
  • [45] Advances in using imaging as an outcome measure in multiple sclerosis
    Miller, D. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 4 - 4
  • [46] The role of MRI as a surrogate outcome measure in multiple sclerosis
    McFarland, HF
    Barkhof, F
    Antel, J
    Miller, DH
    MULTIPLE SCLEROSIS JOURNAL, 2002, 8 (01) : 40 - 51
  • [47] The genetics of clinical outcome in multiple sclerosis
    Ramagopalan, Sreeram V.
    DeLuca, Gabriele C.
    Degenhardt, Alexandra
    Ebers, George C.
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 201 : 183 - 199
  • [48] Is the clinical outcome in multiple sclerosis predictable?
    Confavreux, C
    Grimaud, J
    Vukusic, S
    Moreau, T
    REVUE NEUROLOGIQUE, 1998, 154 (8-9) : 624 - 628
  • [49] Clinical outcome measures in multiple sclerosis
    Amato, Maria Pia
    Portaccio, Emilio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 259 (1-2) : 118 - 122
  • [50] Hazard ratio for recurrent relapses - A modern efficacy measure for clinical trials in relapsing multiple sclerosis
    Bogumil, T
    Jakobs, P
    Salazar-Grueso, E
    Fleming, T
    NEUROLOGY, 2005, 64 (06) : A324 - A324
12345